Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 5
2009 4
2010 5
2011 11
2012 14
2013 20
2014 19
2015 28
2016 11
2017 4
2018 1
2019 2
2021 2
2022 1
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG; Chronic Kidney Disease Prognosis Consortium. Fox CS, et al. Lancet. 2012 Nov 10;380(9854):1662-73. doi: 10.1016/S0140-6736(12)61350-6. Epub 2012 Sep 24. Lancet. 2012. PMID: 23013602 Free PMC article. Review.
ONTARGET still OFF-TARGET?
Lambers Heerspink HJ, de Zeeuw D. Lambers Heerspink HJ, et al. Circulation. 2011 Mar 15;123(10):1049-51. doi: 10.1161/CIRCULATIONAHA.111.018382. Epub 2011 Feb 28. Circulation. 2011. PMID: 21357820 No abstract available.
Microalbuminuria: target for renoprotective therapy PRO.
Roscioni SS, Lambers Heerspink HJ, de Zeeuw D. Roscioni SS, et al. Among authors: lambers heerspink hj. Kidney Int. 2014 Jul;86(1):40-9. doi: 10.1038/ki.2013.490. Epub 2014 Apr 23. Kidney Int. 2014. PMID: 24759154 Free article. Review.
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
Smeijer JD, Kohan DE, Rossing P, Correa-Rotter R, Liew A, Tang SCW, de Zeeuw D, Gansevoort RT, Ju W, Lambers Heerspink HJ. Smeijer JD, et al. Among authors: lambers heerspink hj. Cardiovasc Diabetol. 2023 Sep 16;22(1):251. doi: 10.1186/s12933-023-01964-8. Cardiovasc Diabetol. 2023. PMID: 37716952 Free PMC article.
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering.
Charytan DM, Mahaffey KW, Jardine MJ, Cannon CP, Neal B, Lambers Heerspink HJ, Agarwal R, Bakris GL, de Zeeuw D, Levin A, Pollock C, Zhang H, Zinman B, Rosenthal N, Perkovic V, Di Tanna GL, Yu J, Rogers K, Arnott C, Wheeler DC. Charytan DM, et al. Among authors: lambers heerspink hj. BMJ Open Diabetes Res Care. 2023 Jun;11(3):e003270. doi: 10.1136/bmjdrc-2022-003270. BMJ Open Diabetes Res Care. 2023. PMID: 37311602 Free PMC article. Clinical Trial.
Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis.
Jun M, Turin TC, Woodward M, Perkovic V, Lambers Heerspink HJ, Manns BJ, Tonelli M, Hemmelgarn BR. Jun M, et al. Among authors: lambers heerspink hj. J Am Soc Nephrol. 2015 Sep;26(9):2289-302. doi: 10.1681/ASN.2014040396. Epub 2015 Jan 2. J Am Soc Nephrol. 2015. PMID: 25556165 Free PMC article. Review.
114 results